These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8734458)

  • 1. Glomerular protein trafficking and progression of renal disease to terminal uremia.
    Benigni A; Remuzzi G
    Semin Nephrol; 1996 May; 16(3):151-9. PubMed ID: 8734458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of progression of renal disease: growth factors and related mechanisms.
    Benigni A; Remuzzi G
    J Hypertens Suppl; 1998 Sep; 16(4):S9-12. PubMed ID: 9817186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of increased glomerular protein traffic in the progression of renal failure.
    Bruzzi I; Benigni A; Remuzzi G
    Kidney Int Suppl; 1997 Nov; 62():S29-31. PubMed ID: 9350674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renoprotective action of angiotensin-converting enzyme inhibitors in diabetes.
    Ruggenenti P; Remuzzi G
    Exp Nephrol; 1996; 4 Suppl 1():53-60. PubMed ID: 9001898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin system in progression, remission and regression of chronic nephropathies.
    Aros C; Remuzzi G
    J Hypertens Suppl; 2002 Jun; 20(3):S45-53. PubMed ID: 12184055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of protein uptake through megalin-deficient proximal tubules does not safeguard against tubulointerstitial injury.
    Theilig F; Kriz W; Jerichow T; Schrade P; Hähnel B; Willnow T; Le Hir M; Bachmann S
    J Am Soc Nephrol; 2007 Jun; 18(6):1824-34. PubMed ID: 17460141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.
    Panzer U; Steinmetz OM; Reinking RR; Meyer TN; Fehr S; Schneider A; Zahner G; Wolf G; Helmchen U; Schaerli P; Stahl RA; Thaiss F
    J Am Soc Nephrol; 2006 Feb; 17(2):454-64. PubMed ID: 16382019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators.
    Zoja C; Benigni A; Remuzzi G
    Exp Nephrol; 1999; 7(5-6):420-8. PubMed ID: 10559640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I; Krzymański M
    Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.
    Gong R; Rifai A; Tolbert EM; Biswas P; Centracchio JN; Dworkin LD
    J Am Soc Nephrol; 2004 Nov; 15(11):2868-81. PubMed ID: 15504940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.
    Ruiz-Ortega M; Bustos C; Hernández-Presa MA; Lorenzo O; Plaza JJ; Egido J
    J Immunol; 1998 Jul; 161(1):430-9. PubMed ID: 9647253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase.
    Hung CC; Chang CT; Tian YC; Wu MS; Yu CC; Pan MJ; Vandewalle A; Yang CW
    Nephrol Dial Transplant; 2006 Apr; 21(4):898-910. PubMed ID: 16339163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory.
    Pichler R; Giachelli C; Young B; Alpers CE; Couser WG; Johnson RJ
    Miner Electrolyte Metab; 1995; 21(4-5):317-27. PubMed ID: 7565480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How renal cytokines and growth factors contribute to renal disease progression.
    Benigni A; Remuzzi G
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S21-4. PubMed ID: 11158856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of renin-angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis.
    Imakiire T; Kikuchi Y; Yamada M; Kushiyama T; Higashi K; Hyodo N; Yamamoto K; Oda T; Suzuki S; Miura S
    Hypertens Res; 2007 Jul; 30(7):635-42. PubMed ID: 17785932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubular hypertrophy induced by angiotensin II.
    Wolf G; Ziyadeh FN
    Semin Nephrol; 1997 Sep; 17(5):448-54. PubMed ID: 9316213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?
    Gilbert RE; Cooper ME
    Kidney Int; 1999 Nov; 56(5):1627-37. PubMed ID: 10571771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
    Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
    J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.